Graybug Vision Announces Pricing of Upsized Initial Public Offering Nasdaq:GRAY


REDWOOD CITY, Calif., Sept. 24, 2020 (GLOBE NEWSWIRE) — Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines to treat chronic vision-threatening diseases of the retina and optic nerve, today announced the pricing of its upsized initial public offering of 5,625,000 shares of common stock at a public offering price of $16.00 per share. All of the shares are being offered by Graybug. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Graybug, are expected to be $90.0 million. In addition, Graybug has granted the underwriters a 30-day option to purchase up to an additional 843,750 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Market on September 25, 2020 under the symbol “GRAY.” The offering is expected to close on September…

Click here for the full story.

Infiniti previews next QX60 crossover with Monograph concept

Previous article

BMW fined $18 million for inflating monthly U.S. sales figures

Next article

You may also like

Leave a Reply

Notify of

More in Earnings